Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on March 31, 2025
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
GlobeNewswire
·
March 31, 2025
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of …
Rail Vision Announces Second Half and Full Year 2024 Financial Results: Reports Strong Revenue Growth for the Full Year 2024, Driven by Key Orders and Market Expansion
GlobeNewswire
·
March 31, 2025
Ra’anana, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Rail Vision Ltd. (Nasdaq: RVSN) (“Rail Vision” or the “Company”), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced …
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 2024
GlobeNewswire
·
March 31, 2025
TEL-AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and USA, today …
Aardvark Therapeutics Reports Full Year 2024 Financial Results and Provides Business Highlights
GlobeNewswire
·
March 31, 2025
Lead candidate ARD-101 demonstrated clinical activity and was generally well tolerated in a two-part Phase 2 trial in Prader-Willi Syndrome (PWS), with meaningful reductions in hyperphagia (up to a 16-point HQ-CT reduction, with an average reduction of …
Revolution Medicines to Participate in April 2025 Investor Conferences
GlobeNewswire
·
March 31, 2025
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., …
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
GlobeNewswire
·
March 31, 2025
- Announced preclinical data demonstrating the bioequivalence of RT-114, a GLP-1/GLP-2 dual agonist (PG-102) delivered orally via the RaniPill® capsule, to subcutaneous administration of PG-102 - - Announced preclinical data demonstrating successful oral …
Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings
GlobeNewswire
·
March 31, 2025
WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties
GlobeNewswire
·
March 31, 2025
WOODCLIFF LAKE, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has entered into a royalty purchase agreement with an entity that was provided capital by funds managed …
Fluxx Conference 2025: A Premier Gathering of Business and Healthcare Elites in Middle East
EIN Presswire
·
March 31, 2025
Fluxx Conference 2025: A Premier Gathering of Business and Healthcare Elites in Middle East KALISPELL, MT, UNITED STATES, March 31, 2025 /EINPresswire.com/ -- The highly anticipated Fluxx Conference is set to take place on October 3-4, 2025, at the …
PDAC urges swift, long-term METC extension to bolster Canada’s mineral exploration potential
GlobeNewswire
·
March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- PDAC was encouraged to see a two-year extension of the Mineral Exploration Tax Credit (METC) announced on March 2, 2025, but legislation has not materialized. Ultimately, a long-term solution is essential to …
Launch of MOBIX Park & Charge - The Airbnb for Parking and Charging
EIN Presswire
·
March 31, 2025
PARK. CHARGE. RIDE. EARN. MUNICH, GERMANY, March 31, 2025 /EINPresswire.com/ -- With today’s launch of MOBIX Park …
Director/PDMR Shareholding
GlobeNewswire
·
March 31, 2025
1. Details of the person discharging managerial responsibilities/person closely associated a) Name: Edward Westropp 2. Reason for the notification a) Position/status: Head of Business Development and Corporate Affairs b) Initial notification/Amendment …
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
GlobeNewswire
·
March 31, 2025
More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS survey were satisfied or very satisfied with the initiation regimen, dosing schedule and trial medication1 New data from UZEDY® (risperidone) evaluated predictors of response in …
Mohammad Tabrizian Releases New Book ‘Bridging the Gulf,’ Now Available Online and in Select Bookstores
EIN Presswire
·
March 31, 2025
Mohammad Tabrizian’s new book "Bridging the Gulf" is now available online and in select bookstores across the UK and UAE. HOLBORN, LONDON, UNITED KINGDOM, March 31, 2025 /EINPresswire.com/ -- Renowned public speaker, writer, and cultural communicator …
Burgundy Diamond Mines announces 2024 year-end results
GlobeNewswire
·
March 31, 2025
CALGARY, Alberta, March 31, 2025 (GLOBE NEWSWIRE) -- Burgundy Diamond Mines Limited (ASX:BDM) (Burgundy or the Company) provided the filing of its 2024 Annual Report, including the annual audited financial statements and explanation of results for the …
Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast
GlobeNewswire
·
March 31, 2025
PITTSBURGH, March 31, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that Co- …
Marko Stout Makes His Bold Dubai Debut at Arabesque Royale Gallery
EIN Presswire
·
March 31, 2025
A Global Icon of Contemporary Art Brings His Luxury-Infused Works to the Middle East for the First Time DUBAI, UNITED ARAB EMIRATES, March 30, 2025 /EINPresswire.com/ -- A Global Icon of Contemporary Art Brings His Luxury-Infused Works to the Middle …
Acoramidis Shows Statistically Significant Improvements in Cardiovascular Outcomes in Patients with Variant ATTR-CM
GlobeNewswire
·
March 31, 2025
Acoramidis’s hazard ratio of .41 for time to ACM or first CVH versus placebo in the ATTRibute-CM study subgroup of ATTRv-CM patients achieved statistical significance in a pre-specified analysis This profound treatment effect, due to the near-complete …
Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
GlobeNewswire
·
March 31, 2025
TN-201 Has Been Well Tolerated at 3E13 vg/kg Dose New Biopsy Data Reaffirm Robust Transduction and RNA Expression with TN-201; RNA and Protein Levels Increase Over Time All Cohort 1 Patients with Severe Disease at Baseline Achieved NYHA Class I Two of …
Polyrizon Ltd. Announces $17.0 Million Private Placement
GlobeNewswire
·
March 31, 2025
RAANANA, ISRAEL, March 31, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into definitive agreements with institutional …